Literature DB >> 27009211

O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.

Amena Aktar1, M Arifur Rahman1, Sadia Afrin1, M Omar Faruk1, Taher Uddin1, Aklima Akter1, M Israk Nur Sami1, Tahirah Yasmin1, Fahima Chowdhury1, Ashraful I Khan1, Daniel T Leung2,3, Regina C LaRocque2,3, Richelle C Charles2,3, Taufiqur Rahman Bhuiyan1, Anjali Mandlik2, Meagan Kelly2, Pavol Kováč4, Peng Xu4, Stephen B Calderwood2,3,5, Jason B Harris2,6,7, Firdausi Qadri1, Edward T Ryan8,3,9.   

Abstract

Cholera caused by Vibrio cholerae O1 confers at least 3 to 10 years of protection against subsequent disease regardless of age, despite a relatively rapid fall in antibody levels in peripheral blood, suggesting that memory B cell responses may play an important role in protection. The V. cholerae O1-specific polysaccharide (OSP) component of lipopolysaccharide (LPS) is responsible for serogroup specificity, and it is unclear if young children are capable of developing memory B cell responses against OSP, a T cell-independent antigen, following cholera. To address this, we assessed OSP-specific memory B cell responses in young children (2 to 5 years, n = 11), older children (6 to 17 years, n = 21), and adults (18 to 55 years, n = 28) with cholera caused by V. cholerae O1 in Dhaka, Bangladesh. We also assessed memory B cell responses against LPS and vibriocidal responses, and plasma antibody responses against OSP, LPS, and cholera toxin B subunit (CtxB; a T cell-dependent antigen) on days 2 and 7, as well as days 30, 90, and 180 after convalescence. In all age cohorts, vibriocidal responses and plasma OSP, LPS, and CtxB-specific responses peaked on day 7 and fell toward baseline over the follow-up period. In comparison, we were able to detect OSP memory B cell responses in all age cohorts of patients with detectable responses over baseline for 90 to 180 days. Our results suggest that OSP-specific memory B cell responses can occur following cholera, even in the youngest children, and may explain in part the age-independent induction of long-term immunity following naturally acquired disease.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27009211      PMCID: PMC4860469          DOI: 10.1128/CVI.00647-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  52 in total

1.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

3.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

4.  Descriptive spatial analysis of the cholera epidemic 2008-2009 in Harare, Zimbabwe: a secondary data analysis.

Authors:  Miguel Ángel Luque Fernández; Peter R Mason; Henry Gray; Ariane Bauernfeind; Jean François Fesselet; Peter Maes
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-13       Impact factor: 2.184

5.  Refractory periods and climate forcing in cholera dynamics.

Authors:  Katia Koelle; Xavier Rodó; Mercedes Pascual; Md Yunus; Golam Mostafa
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

Review 6.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

7.  Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.

Authors:  M J Albert; K Alam; M Ansaruzzaman; F Qadri; R B Sack
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

Review 8.  Cholera toxin - a foe & a friend.

Authors:  Joaquin Sanchez; Jan Holmgren
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

9.  Epidemiology of cholera outbreak in Kampala, Uganda.

Authors:  D Legros; M McCormick; C Mugero; M Skinnider; D D Bek'Obita; S I Okware
Journal:  East Afr Med J       Date:  2000-07

10.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more
  15 in total

1.  Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.

Authors:  Danielle E Baranova; Graham G Willsey; Kara J Levinson; Carol Smith; Joseph Wade; Nicholas J Mantis
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

2.  Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.

Authors:  Danielle E Baranova; Kara J Levinson; Nicholas J Mantis
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

3.  Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh.

Authors:  Richelle C Charles; Rie Nakajima; Li Liang; Al Jasinskas; Amanda Berger; Daniel T Leung; Meagan Kelly; Peng Xu; Pavol Kovác; Samantha R Giffen; James D Harbison; Fahima Chowdhury; Ashraful I Khan; Stephen B Calderwood; Taufiqur Rahman Bhuiyan; Jason B Harris; Philip L Felgner; Firdausi Qadri; Edward T Ryan
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

4.  Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.

Authors:  Amena Aktar; M Arifur Rahman; Sadia Afrin; Aklima Akter; Taher Uddin; Tahirah Yasmin; Md Israk Nur Sami; Pinki Dash; Sultana Rownok Jahan; Fahima Chowdhury; Ashraful I Khan; Regina C LaRocque; Richelle C Charles; Taufiqur Rahman Bhuiyan; Anjali Mandlik; Meagan Kelly; Pavol Kováč; Peng Xu; Stephen B Calderwood; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2018-04-23

5.  Estimating cholera incidence with cross-sectional serology.

Authors:  Andrew S Azman; Justin Lessler; Francisco J Luquero; Taufiqur Rahman Bhuiyan; Ashraful Islam Khan; Fahima Chowdhury; Alamgir Kabir; Marc Gurwith; Ana A Weil; Jason B Harris; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri; Daniel T Leung
Journal:  Sci Transl Med       Date:  2019-02-20       Impact factor: 17.956

6.  Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.

Authors:  Aklima Akter; Pinki Dash; Amena Aktar; Sultana Rownok Jahan; Sadia Afrin; Salima Raiyan Basher; Al Hakim; Asura Khanam Lisa; Fahima Chowdhury; Ashraful I Khan; Peng Xu; Richelle C Charles; Meagan Kelly; Pavol Kováč; Jason B Harris; Taufiqur Rahman Bhuiyan; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  PLoS Negl Trop Dis       Date:  2019-08-01

7.  Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.

Authors:  Motaher Hossain; Kamrul Islam; Meagan Kelly; Leslie M Mayo Smith; Richelle C Charles; Ana A Weil; Taufiqur Rahman Bhuiyan; Pavol Kováč; Peng Xu; Stephen B Calderwood; Jakub K Simon; Wilbur H Chen; Michael Lock; Caroline E Lyon; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Daniel T Leung; Andrew S Azman; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2019-11-19

8.  Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.

Authors:  Fahima Chowdhury; Taufiqur Rahman Bhuiyan; Afroza Akter; Md Saruar Bhuiyan; Ashraful Islam Khan; Imam Tauheed; Tasnuva Ahmed; Jannatul Ferdous; Pinki Dash; Salima Raiyan Basher; Al Hakim; Julia Lynch; Jerome H Kim; Jean-Louis Excler; Deok Ryun Kim; John D Clemens; Firdausi Qadri
Journal:  Vaccine       Date:  2019-12-24       Impact factor: 3.641

9.  Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.

Authors:  Anita S Iyer; Andrew S Azman; Malika Bouhenia; Lul O Deng; Cole P Anderson; Michael Graves; Pavol Kováč; Peng Xu; Edward T Ryan; Jason B Harris; David A Sack; Francisco J Luquero; Daniel T Leung
Journal:  PLoS Negl Trop Dis       Date:  2018-01-29

10.  Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk.

Authors:  Danielle E Baranova; Lihow Chen; Margaret Destrempes; Harry Meade; Nicholas J Mantis
Journal:  Pathog Immun       Date:  2020-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.